Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010807-10Phase 3Active
Phase 3, randomised trial in None comparing Intrathecal bupivacaine + sufentanil, Intrathecal levobupivacaine + sufentanil and Intrathecal ropivacaine + sufentanil (3 arms). Primary endpoint: Block efficacy. Started May 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010807-10.